Exagen misses consensus with loss per share
XGN Exagen Inc
$5.03 -4.28%
View chart & analysis → - 1Exagen reported a loss of $0.25 per share, missing consensus by 31.6% at -$0.19.
- 2Exagen revenue of $18.42 million recorded a year-over-year growth rate of 6.8%.
- 3Management reaffirmed the annual revenue guidance of $72 million to $75 million.
So what's the key point?
Exagen recorded a larger loss than experts expected. Revenue reached $18.42 million, and management reaffirmed its annual revenue outlook.
Source Earnings Whispers · View original ↗
Today's 5 AI picks, all freeNothing hidden: past picks and how they did against the S&P 500.